Page last updated: 2024-10-22

alpha-methylserotonin and Inflammation

alpha-methylserotonin has been researched along with Inflammation in 2 studies

alpha-methylserotonin: potent agonist at M & D receptors of serotonin; RN given refers to parent cpd

Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Research Excerpts

ExcerptRelevanceReference
"The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined."7.73Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005)
"The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined."3.73Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishiyama, T1
Tozawa, Y1
Matsushima, K1

Other Studies

2 other studies available for alpha-methylserotonin and Inflammation

ArticleYear
Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain.
    European journal of pharmacology, 2005, May-23, Volume: 516, Issue:1

    Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation;

2005
Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation.
    European journal of pharmacology, 2002, Apr-05, Volume: 440, Issue:1

    Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamin

2002